Digital PCR vs. Real-Time PCR

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-27

Quick Answer

• Digital PCR provides absolute quantification by partitioning a sample into thousands of individual reactions, while real-time PCR relies on standard curves and cycle threshold values for relative measurement.
• Choose digital PCR when you need absolute copy numbers, rare allele detection, or tolerance to inhibitors, and choose real-time PCR for high-throughput screening, lower cost per sample, and established clinical workflows.
• Both methods require rigorous controls and standardized reporting, and neither eliminates the need for proper RNA quality assessment, reverse transcription efficiency checks, or contamination prevention.

At a Glance

Quantification Principles

Real-Time PCR Measures Amplification in Real Time

Real-time PCR, also called quantitative PCR or qPCR, monitors the accumulation of amplified DNA after each cycle by measuring fluorescence. The instrument records the cycle at which fluorescence rises above a background threshold, known as the quantification cycle or Cq value. This Cq value is inversely proportional to the starting amount of target nucleic acid. A sample with more starting template reaches the threshold earlier, producing a lower Cq value, while a sample with less template requires more cycles to generate detectable fluorescence.

The relationship between Cq and starting quantity is not absolute. It depends on amplification efficiency, which can vary with primer design, template quality, and the presence of inhibitors. For relative quantification, the Cq of a target gene is compared to the Cq of a reference gene in the same sample. For absolute quantification, you must generate a standard curve using known concentrations of a standard material, then interpolate the Cq values of your unknown samples against that curve.

The MIQE guidelines emphasize that qPCR results are only meaningful when you report the reaction conditions, the efficiency of the assay, the choice of reference genes, and the method of data analysis. Without this information, a Cq value has limited interpretive value because it cannot be compared across laboratories or even across runs in the same laboratory.

Digital PCR Counts Positive Partitions

Digital PCR works on a different principle. The sample is divided into thousands or millions of individual partitions, each containing either zero or one copy of the target sequence. After amplification, each partition is scored as positive or negative for the target. The proportion of positive partitions is used to calculate the absolute number of target molecules in the original sample using Poisson statistics, which corrects for the probability that a partition may contain more than one copy.

Because the measurement is based on counting positive and negative reactions instead of on the timing of fluorescence, digital PCR does not require a standard curve. The absolute copy number is calculated directly from the number of positive partitions and the total number of partitions analyzed. This makes digital PCR less sensitive to differences in amplification efficiency between runs, because the endpoint readout is binary, either positive or negative.

The partitioning step is the defining feature of digital PCR. Some platforms use microfluidic chambers, while others use droplet generation to create water-in-oil emulsions. The choice of platform affects the number of partitions, the volume of each partition, and the dynamic range of the assay. The NIST laboratory programs provide measurement science and standards context for the calibration and quality assurance of such quantitative methods.

The Difference Between Relative and Absolute Measurement

The core distinction between the two methods is the type of measurement they produce. Real-time PCR produces a relative measurement that depends on the amplification curve and the reference material. Digital PCR produces an absolute count that does not depend on a standard curve.

This distinction matters for applications where the exact number of copies is important. For example, measuring the copy number of a transgene, detecting a rare mutation in a background of wild-type DNA, or quantifying a viral load requires an absolute count. Real-time PCR can provide absolute numbers only when a reliable standard curve is available, and the accuracy of that curve depends on the quality of the standards and the consistency of the amplification.

Digital PCR also has a different sensitivity profile. Because the sample is partitioned, the background signal from the bulk reaction is reduced. This allows digital PCR to detect rare targets that might be missed by real-time PCR, where the fluorescence from the abundant background can obscure the signal from the rare target.

Workflow and Practical Implementation

Sample Preparation and Nucleic Acid Extraction

Both methods begin with the same upstream steps: sample collection, nucleic acid extraction, and quality assessment. The quality of the input material determines the reliability of the downstream quantification. Degraded RNA or DNA, residual inhibitors, and inconsistent extraction yields will affect both methods, although the impact may differ.

For RNA targets, the reverse transcription step is a critical source of variability. The efficiency of reverse transcription can vary between samples and between runs, and this variability is carried into the quantification step. The MIQE guidelines recommend that you report the reverse transcription protocol, the amount of input RNA, and the efficiency of the reaction. For digital PCR, the reverse transcription step is still required for RNA targets, and the partitioning occurs after the reverse transcription.

Real-Time PCR Workflow

The real-time PCR workflow is well established and widely used. You prepare a reaction mix containing the DNA polymerase, primers, a fluorescent probe or dye, and the template. The reaction is placed in a thermal cycler that measures fluorescence after each cycle. The instrument software calculates the Cq value for each reaction and generates an amplification curve.

The workflow requires careful optimization of the primer and probe concentrations, the annealing temperature, and the magnesium concentration. The Addgene protocols provide educational context for the practical planning of molecular biology workflows, including the design and testing of primers and the preparation of reaction mixes. These protocols are useful for planning, but they are not universally validated and must be optimized for your specific assay.

Digital PCR Workflow

The digital PCR workflow adds a partitioning step. After the reaction mix is prepared, the sample is divided into partitions. Each partition is then amplified, and the fluorescence is read at the end of the reaction. The instrument counts the number of positive and negative partitions and calculates the absolute copy number.

The partitioning step requires specialized equipment. Some platforms use a chip with thousands of micro wells, while others use a droplet generator that creates an emulsion. The choice of platform affects the number of partitions and the volume of each partition, which in turn affects the dynamic range and the sensitivity of the assay.

Reverse Transcription PCR for RNA Targets

Both methods can be used for RNA targets, but the reverse transcription step must be performed before the PCR. The reverse transcription converts the RNA into complementary DNA, which is then amplified. The efficiency of the reverse transcription is a major source of variability, and it must be controlled for both methods.

For real-time PCR, the reverse transcription is often performed in the same tube as the PCR, using a one-step protocol. For digital PCR, the reverse transcription is typically performed separately, and the resulting cDNA is then partitioned. The choice of protocol affects the workflow and the potential for variability.

Sensitivity and Rare Target Detection

The Challenge of Rare Target Detection

Detecting a rare target in a large background of nontarget DNA is a common challenge in molecular biology. Examples include detecting a single mutant allele in a background of wild-type DNA, quantifying a low-level viral load, or detecting a rare transcript in a complex RNA population.

Real-time PCR has a fundamental limitation in this context. The fluorescence signal from the abundant background can obscure the signal from the rare target. The Cq value is a bulk measurement, and it cannot distinguish between a sample with a small amount of target and a sample with a large amount of background that produces a similar fluorescence signal.

How Digital PCR Improves Rare Target Detection

Digital PCR improves rare target detection by partitioning the sample. Each partition contains a small number of template molecules, and the background is diluted across the partitions. A rare target is more likely to be isolated in a partition without the background, allowing the positive signal to be detected.

The sensitivity of digital PCR is limited by the number of partitions and the total volume of the sample. A higher number of partitions increases the chance of detecting a rare target, but it also increases the cost and the complexity of the assay. The dynamic range of the assay is determined by the number of partitions and the volume of each partition.

The Role of the Reference in Real-Time PCR

The sensitivity of real-time PCR is also affected by the reference material. For absolute quantification, you must use a standard curve generated from a known concentration of the target. The accuracy of the standard curve depends on the quality of the standard and the consistency of the reaction. If the standard is degraded or the reaction efficiency varies, the absolute values will be inaccurate.

The MIQE guidelines recommend that you report the efficiency of the standard curve and the range of the standard concentrations. This information allows the reader to assess the reliability of the absolute values.

Controls and Quality Assurance

The Importance of Controls

Both methods require a set of controls to ensure the validity of the results. The controls include a no-template control to detect contamination, a positive control to confirm the assay is working, and a reverse transcription control for RNA targets.

The no-template control is a reaction that contains all the components except the template. It should produce no amplification. If it produces a signal, the reagents are contaminated, and the results are invalid.

The positive control is a reaction with a known amount of the target. It confirms that the assay is working and that the reagents are functional. The positive control should produce a signal within the expected range.

The MIQE Guidelines for Reporting

The MIQE guidelines provide a framework for the reporting of real-time PCR experiments. They recommend that you report the reaction conditions, the efficiency of the assay, the reference genes used, and the controls. This information allows the reader to assess the reliability of the results and to compare results across laboratories.

The guidelines also recommend that you report the method of data analysis, including the threshold setting and the method for calculating the Cq value. This is important because the threshold setting can affect the Cq value and the final results.

Quality Control for Digital PCR

Digital PCR also requires quality control. The number of partitions analyzed must be sufficient for the desired sensitivity. The instrument should be calibrated, and the reagents should be validated. The NIST laboratory programs provide context for the measurement science and quality control that underpin quantitative methods.

For digital PCR, the quality of the partitioning is critical. If the partitions are not uniform in volume, the calculation of the absolute copy number will be inaccurate. The instrument should be checked regularly to ensure that the partitioning is consistent.

Common Failure Patterns and Troubleshooting

Real-Time PCR Failure Patterns

Real-time PCR can fail for several reasons. The most common are poor primer design, suboptimal reaction conditions, and the presence of inhibitors in the sample. The amplification curve can reveal the problem. A curve that does not reach the plateau suggests a low amplification efficiency. A curve that rises and then falls suggests a problem with the probe or the reaction.

The Addgene protocols provide educational context for the design and testing of primers. The primer should be specific to the target and should not form dimers or secondary structures. The annealing temperature should be optimized for the primer pair.

Digital PCR Failure Patterns

Digital PCR can fail in several ways. The most common is the failure of the partitioning step. If the partitions are not formed correctly, the number of positive partitions will be inaccurate. The instrument should be checked for proper operation.

Another failure pattern is the presence of a positive signal in the no-template control. This indicates contamination of the reagents or the environment. The source of the contamination must be identified and eliminated.

The Role of the Reference in Troubleshooting

The reference is a critical component of the real-time PCR assay. If the reference is not stable or the concentration is not accurate, the results will be incorrect. The reference should be validated before use, and the concentration should be confirmed by an independent method.

For digital PCR, the reference is not required for the absolute quantification. However, the reference can be used to validate the assay and to confirm the accuracy of the results.

Biosafety and Regulatory Context

Biosafety Principles for PCR Work

PCR work involves the amplification of nucleic acids, which can be a biohazard if the target is a pathogen or a recombinant molecule. The Biosafety in Microbiological and Biomedical Laboratories provides the principles for risk assessment, containment, and institutional oversight. The level of containment required depends on the nature of the target and the risk of exposure.

For work with recombinant or synthetic nucleic acid molecules, the NIH Guidelines for Recombinant or Synthetic Nucleic Acid Molecules provide the official oversight context. These guidelines specify the containment and the practices required for the work.

Institutional Oversight and Approval

The work with recombinant or synthetic nucleic acid molecules requires institutional approval. The Institutional Biosafety Committee reviews the proposed work and determines the required containment level. The work cannot begin until the approval is granted.

The Biosafety in Microbiological and Biomedical Laboratories provides the principles for the risk assessment and the containment. The risk assessment should consider the nature of the target, the concentration, and the potential for exposure.

The Role of the Laboratory Professional

The laboratory professional is responsible for the safe conduct of the work. The professional must follow the approved protocols and the containment requirements. The professional must also report any incidents or exposures to the institutional oversight.

The NIH Guidelines for Recombinant or Synthetic Nucleic Acid Molecules specify the responsibilities of the principal investigator and the institution. The principal investigator is responsible for the conduct of the work and for the training of the personnel.

Decision Tree for Method Selection

The choice between digital PCR and real-time PCR depends on the specific requirements of the experiment. The following decision tree can help you select the appropriate method.

flowchart TD
    A[What is the goal of the experiment?] --> B[Absolute quantification or rare target detection?]
    B -->|Yes| C[Digital PCR]
    B -->|No| D{High-throughput screening or relative expression?}
    D -->|Yes| E[Real-Time PCR]
    D -->|No| F{Is a standard curve available and validated?}
    F -->|Yes| G[Real-Time PCR with standard curve]
    F -->|No| H[Digital PCR]

The decision tree is a starting point. The final decision should consider the cost, the throughput, the sensitivity, and the available equipment.

When to Use Digital PCR

Digital PCR is the preferred method when you need absolute quantification. This includes the detection of rare alleles, the measurement of copy number variation, and the quantification of viral load. Digital PCR is also useful when the amplification efficiency is variable or when the reference is not available.

The NIST laboratory programs provide context for the measurement science that underpins the absolute quantification. The accuracy of the digital PCR result depends on the quality of the partitioning and the statistical analysis.

When to Use Real-Time PCR

Real-time PCR is the preferred method for high-throughput screening and for relative expression analysis. It is also the method of choice when the cost per sample is a concern. The real-time PCR workflow is well established and the reagents are widely available.

The MIQE guidelines provide the framework for the reporting of the real-time PCR results. The guidelines ensure that the results are transparent and reproducible.

The Role of the Standard Curve

The standard curve is a critical component of the real-time PCR assay for absolute quantification. The standard curve must be validated and the efficiency must be reported. If the standard curve is not reliable, the absolute values will be inaccurate.

For digital PCR, the standard curve is not required. The absolute copy number is calculated directly from the number of positive partitions. This makes digital PCR more robust to the variability of the amplification efficiency.

Records and Measurements

The Data to Record for Real-Time PCR

For real-time PCR, you should record the Cq value for each sample, the efficiency of the assay, the standard curve, and the controls. The Cq value is the primary measurement, and it is used for the relative quantification. The efficiency of the assay is calculated from the standard curve and should be reported.

The MIQE guidelines specify the information that should be reported for the real-time PCR experiments. This includes the reaction conditions, the primers, the probes, and the controls.

The Data to Record for Digital PCR

For digital PCR, you should record the number of positive partitions, the total number of partitions, and the calculated copy number. The number of positive partitions is the primary measurement, and it is used for the statistical analysis.

The quality of the data depends on the number of partitions analyzed. A larger number of partitions provides a more accurate estimate of the copy number. The instrument should be validated to ensure that the partitioning is consistent.

The Use of the Records

The records are used for the interpretation of the results and for the comparison across runs. The records also provide the basis for the troubleshooting and the quality control. The records should be stored in a secure location and should be accessible for the review.

The NIST laboratory programs provide the context for the measurement science and the quality control. The records are the basis for the measurement assurance and the traceability.

Limitations and Interpretation

The Limitations of Real-Time PCR

Real-time PCR has several limitations. The Cq value is a relative measurement, and it depends on the amplification efficiency and the reference. The absolute quantification requires a standard curve, which is subject to the variability of the standard. The sensitivity for rare targets is limited by the background signal.

The MIQE guidelines emphasize that the results of the real-time PCR are only meaningful when the reaction conditions are reported. The efficiency of the assay must be reported, and the reference must be validated.

The Limitations of Digital PCR

Digital PCR has its own limitations. The cost per sample is higher than the real-time PCR, and the throughput is lower. The partitioning step requires specialized equipment, and the analysis is more complex. The dynamic range is limited by the number of partitions and the volume of each partition.

The accuracy of the digital PCR depends on the quality of the partitioning. If the partitions are not uniform in volume, the calculation of the copy number will be inaccurate. The instrument must be validated regularly.

The Professional Escalation Criteria

The laboratory professional should escalate the issue to the supervisor or the institutional oversight when the results are inconsistent or when the quality control fails. The escalation should include the data and the description of the problem.

The professional should also escalate the issue when the safety is a concern. The Biosafety in Microbiological and Biomedical Laboratories provides the principles for the risk assessment and the containment. The professional should follow the approved containment and the reporting requirements.

A Practical Decision Framework for Method Selection Based on Assay Requirements

Defining the Quantification Objective Before Instrument Selection

The first decision point is not the instrument but the nature of the answer you need. Write down the primary question of the experiment in quantitative terms. For example, "How many copies of the target are present per microliter of extracted nucleic acid" is an absolute question. "Did the treatment change the expression of the target relative to a control group" is a relative question. These two questions lead to different methods because the measurement principles differ.

For absolute questions, digital PCR provides a direct count of target molecules without a standard curve. For relative questions, real-time PCR with a validated reference gene is the established approach. The MIQE guidelines state that the choice of quantification strategy should be determined by the biological question and that the method must be reported with sufficient detail to allow evaluation of its reliability.

A second criterion is the expected abundance of the target. If you expect the target to be present at a low copy number, such as a rare mutation in a background of wild-type DNA, the partitioning of digital PCR reduces the background signal that can obscure the rare target. If the target is expected to be abundant, real-time PCR is often sufficient and more economical.

A third criterion is the tolerance for amplification efficiency variation. Real-time PCR absolute quantification depends on the efficiency of the amplification reaction, which is calculated from the standard curve. If the efficiency varies between runs or between samples, the absolute values will be inaccurate. Digital PCR is less sensitive to this variation because the endpoint readout is binary, either positive or negative, and the copy number is calculated from the proportion of positive partitions.

The Assumption Audit for Real-Time PCR Absolute Quantification

Before using real-time PCR for absolute quantification, you must verify a set of assumptions. These assumptions are often not tested, and their failure is a common source of inaccurate results.

The first assumption is that the standard curve is accurate. The standard must be a known concentration of the target sequence, and the concentration must be verified by an independent method. The NIST laboratory programs provide context for the measurement science that underpins the calibration of standards. If the standard is degraded or the concentration is inaccurate, the absolute values will be wrong.

The second assumption is that the amplification efficiency is consistent across the standard and the unknown samples. The efficiency is calculated from the slope of the standard curve. An efficiency between 90 and 110 percent is generally considered acceptable, but this range is not universal and must be validated for each assay. The MIQE guidelines recommend that the efficiency be reported and that the standard curve be run in the same plate as the unknown samples.

The third assumption is that the sample matrix does not inhibit the reaction. Inhibitors in the sample can reduce the amplification efficiency and produce a higher Cq value, which leads to an underestimation of the target quantity. The no-template control and a spike-in control can detect inhibition. A spike-in control is a known amount of a second target that is added to the sample, and the recovery of the spike-in is measured.

The fourth assumption is that the reference gene is stable across the experimental conditions. For relative quantification, the reference gene must not change in expression between the control and the treatment groups. The stability of the reference gene must be validated for each experimental system. The MIQE guidelines recommend that the reference gene be validated and that the stability be reported.

The Partition Count Audit for Digital PCR

Digital PCR also requires a set of assumptions to be verified. The first is that the number of partitions is sufficient for the desired sensitivity. The sensitivity of digital PCR is limited by the number of partitions and the total volume of the sample. A higher number of partitions increases the chance of detecting a rare target, but it also increases the cost. The limit of detection is the smallest number of copies that can be distinguished from zero with a defined confidence.

The second assumption is that the partitions are uniform in volume. If the partitions are not uniform, the calculation of the copy number will be inaccurate. The instrument should be checked regularly to ensure that the partitioning is consistent. The NIST laboratory programs provide context for the measurement assurance that underpins the quality of the partitioning.

The third assumption is that the Poisson statistics are applied correctly. The proportion of positive partitions is used to calculate the average number of copies per partition, and this value is then multiplied by the total number of partitions to obtain the copy number. The Poisson correction accounts for the probability that a partition may contain more than one copy. If the number of positive partitions is too high, the Poisson correction becomes less accurate, and the dynamic range is exceeded.

The fourth assumption is that the no-template control is negative. A positive signal in the no-template control indicates contamination of the reagents or the environment. The source of the contamination must be identified and eliminated before the results can be interpreted.

A Stepwise Decision Protocol for Method Selection

The following protocol provides a structured approach to method selection. The protocol is based on the assumptions described above and is designed to be used in the laboratory before the experiment begins.

Step one is to define the primary question. Write the question in a single sentence. If the question asks for a copy number, a concentration, or a ratio of two targets, the method must provide an absolute value. If the question asks for a change in expression or a comparison between groups, the method must provide a relative value.

Step two is to estimate the expected abundance of the target. Use the available literature or a preliminary experiment to estimate the copy number or the Cq value. If the target is expected to be present at a low copy number, such as below the reliable range of the real-time PCR, consider digital PCR.

Step three is to assess the availability of a validated standard. If a standard curve is available and the efficiency is within the acceptable range, real-time PCR can provide absolute values. If a standard is not available or the efficiency is variable, digital PCR is the preferred method.

Step four is to consider the throughput and the cost. Real-time PCR is the preferred method for high-throughput screening and for relative expression analysis. Digital PCR is the preferred method for absolute quantification and rare target detection, but the cost per sample is higher.

Step five is to document the decision. The decision should be recorded in the laboratory notebook, including the rationale for the choice and the assumptions that were verified. The MIQE guidelines recommend that the method of quantification be reported in the final publication.

The Record System for Method Validation and Comparison

A record system is essential for the validation and the comparison of the two methods. The record should include the following information for each experiment.

For real-time PCR, record the Cq value for each sample, the efficiency of the assay, the standard curve, and the controls. The Cq value is the primary measurement, and it is used for the relative quantification. The efficiency of the assay is calculated from the standard curve and should be reported. The MIQE guidelines specify the information that should be reported for the real-time PCR experiments.

For digital PCR, record the number of positive partitions, the total number of partitions, and the calculated copy number. The number of positive partitions is the primary measurement, and it is used for the statistical analysis. The quality of the data depends on the number of partitions analyzed. A larger number of partitions provides a more accurate estimate of the copy number.

The record should also include the date, the operator, the instrument, the reagent lot numbers, and the thermal cycling conditions. This information is necessary for the troubleshooting and the quality control. The records should be stored in a secure location and should be accessible for the review.

The Comparison Experiment for Method Verification

If you are considering a change from real-time PCR to digital PCR, or if you need to compare the two methods for a specific application, a comparison experiment is recommended. The comparison experiment should be designed to test the assumptions of both methods.

The first step is to prepare a dilution series of a known target. The dilution series should cover the expected range of the target concentration. The same dilution series should be run on both instruments.

The second step is to analyze the data. For real-time PCR, calculate the Cq value for each dilution and generate a standard curve. For digital PCR, calculate the copy number for each dilution. The results should be compared to the expected concentration of the dilution series.

The third step is to assess the accuracy and the precision. The accuracy is the closeness of the measured value to the expected value. The precision is the reproducibility of the measurement. The NIST laboratory programs provide the context for the measurement science that underpins the assessment of accuracy and precision.

The fourth step is to document the results. The comparison experiment should be recorded in the laboratory notebook, and the results should be used to inform the method selection for future experiments.

The Common Failure Patterns in the Method Selection

The most common failure pattern in the method selection is the use of real-time PCR for absolute quantification without a validated standard curve. This failure produces inaccurate absolute values that cannot be compared across runs or across laboratories. The MIQE guidelines emphasize that the standard curve must be validated and the efficiency must be reported.

The second common failure pattern is the use of digital PCR for a relative expression analysis. The digital PCR provides an absolute copy number, but the relative expression analysis requires a reference gene and a comparison between groups. The digital PCR can be used for the relative expression analysis, but the workflow is more complex and the cost is higher.

The third common failure pattern is the failure to verify the assumptions. The assumptions of the amplification efficiency, the standard curve, the partition uniformity, and the Poisson statistics must be verified for each assay. The failure to verify the assumptions produces results that are not reliable.

The fourth common failure pattern is the failure to record the data. The records are the basis for the troubleshooting and the quality control. The failure to record the data makes it impossible to identify the source of the problem.

The Professional Escalation Criteria for the Method Selection

The laboratory professional should escalate the issue to the supervisor or the institutional oversight when the results are inconsistent or when the quality control fails. The escalation should include the data and the description of the problem.

The professional should also escalate the issue when the safety is a concern. The Biosafety in Microbiological and Biomedical Laboratories provides the principles for the risk assessment and the containment. The professional should follow the approved containment and the reporting requirements.

The professional should escalate the issue when the method selection is not clear. The decision matrix and the assumption audit are tools to support the decision, but the final decision should be made in consultation with the supervisor or the institutional review. The NIH Guidelines for Recombinant or Synthetic Nucleic Acid Molecules provide the official oversight context for the work with recombinant molecules.

The Use of the Decision Matrix in the Laboratory

The decision matrix is a practical tool that can be used in the laboratory. The matrix is not a substitute for the professional judgment, but it provides a structured way to evaluate the options. The matrix should be used at the beginning of the experiment, and the decision should be recorded in the laboratory notebook.

The matrix is based on the assumptions that are verified in the audit. The audit is a checklist that ensures the assumptions are tested before the data is collected. The audit is a quality control measure that reduces the risk of the inaccurate results.

The matrix and the audit are not a one-time activity. They should be used for each experiment, and the results should be reviewed by the laboratory. The review is an opportunity to identify the patterns and to improve the workflow.

The Integration of the Decision Matrix with the Existing Workflow

The decision matrix can be integrated with the existing workflow of the laboratory. The matrix is used at the beginning of the experiment, and the audit is used during the experiment. The records are used at the end of the experiment for the interpretation and the reporting.

The integration of the matrix with the existing workflow does not require a change in the instrumentation or the reagents. The matrix is a decision tool, and the audit is a quality control tool. The tools are used to improve the reliability of the results.

The integration of the matrix is also a training tool. The matrix can be used to train the new personnel in the method selection and the quality control. The matrix provides a structured way to the decision, and the audit provides a structured way to the verification.

The Addgene protocols provide educational context for the practical planning of the molecular biology workflows. The protocols are useful for the planning, but they are not universally validated and must be optimized for the specific assay. The decision matrix and the audit are the tools that are used to ensure the reliability of the results.

Frequently Asked Questions

What is the main difference between digital PCR and real-time PCR?

Digital PCR counts the number of positive and negative partitions to calculate an absolute copy number, while real-time PCR measures the cycle at which fluorescence rises above a threshold to produce a relative or standard-curve-based value. The difference is the principle of the measurement, not the amplification chemistry.

When should I use digital PCR instead of real-time PCR?

Use digital PCR when you need absolute quantification, such as for the detection of rare alleles, the measurement of copy number variation, or the quantification of a viral load. Use real-time PCR for high-throughput screening and relative expression analysis.

Does digital PCR require a standard curve?

No, digital PCR does not require a standard curve. The absolute copy number is calculated directly from the number of positive partitions. Real-time PCR requires a standard curve for absolute quantification.

Can digital PCR detect rare targets that real-time PCR misses?

Digital PCR can detect rare targets more reliably because the sample is partitioned and the background is diluted. The sensitivity is limited by the number of partitions and the total volume of the sample.

What is the role of the reverse transcription step in both methods?

The reverse transcription step converts RNA into cDNA before the PCR. The efficiency of the reverse transcription affects the results of both methods. The reverse transcription must be controlled and reported.

How do the MIQE guidelines affect the reporting of real-time PCR results?

The MIQE guidelines specify the minimum information that should be reported for the real-time PCR experiments. This includes the reaction conditions, the efficiency, the reference, and the controls. The guidelines ensure the transparency and the reproducibility of the results.

What are the biosafety considerations for PCR work?

PCR work involves the amplification of nucleic acids, which can be a biohazard if the target is a pathogen or a recombinant molecule. The Biosafety in Microbiological and Biomedical Laboratories provides the principles for the risk assessment and the containment. The work with recombinant molecules requires the institutional approval.

How do I choose between digital PCR and real-time PCR for my experiment?

The choice depends on the purpose of the experiment. If you need absolute quantification or rare target detection, use digital PCR. If you need high-throughput screening or relative expression analysis, use real-time PCR. Consider the cost, the throughput, and the available equipment.

Using the Evidence

Related Molecular Biology Guides

• Mycoplasma Contamination PCR: Detection and Prevention
• PCR Reaction: Principles, Steps, and Applications
• PCR Testing: Principles, Workflow, and Applications
• PCR Types and Their Applications: A Comprehensive Guide
• Annealing at Room Temperature: Mechanisms and PCR Applications

References and Further Reading

• Molecular Biology and Laboratory Methods. National Library of Medicine.
• Biosafety in Microbiological and Biomedical Laboratories. CDC and NIH.
• NIH Guidelines for Recombinant or Synthetic Nucleic Acid Molecules. National Institutes of Health.
• Addgene Protocols. Addgene.
• MIQE Guidelines. Clinical Chemistry.
• NIST Laboratory Programs. National Institute of Standards and Technology.
• Droplet digital PCR vs. quantitative real time-PCR for diagnosis of pulmonary and extrapulmonary tuberculosis: systematic review and meta-analysis.. Frontiers in medicine, 2023.
• Comparison of droplet digital PCR vs real-time PCR for Yersinia enterocolitica detection in vegetables.. International journal of food microbiology, 2021.
• Accuracy of real-time PCR and digital PCR for the monitoring of total HIV DNA under prolonged antiretroviral therapy.. Scientific reports, 2022.
• Reverse transcriptase droplet digital PCR vs reverse transcriptase quantitative real-time PCR for serum HBV RNA quantification.. Journal of medical virology, 2020.
• Detection of EGFR T790M mutation using liquid biopsy for non-small cell lung cancer: Utility of droplet digital polymerase chain reaction vs. cobas real-time polymerase chain reaction.. Pathology, research and practice, 2024.

This article is educational and does not replace validated laboratory procedures, institutional biosafety review, manufacturer instructions, or professional interpretation.